Clinical Trials and Research Staff at Florida Cancer Specialists & Research Institute
Advanced, New Therapies and Technology
Early and late-phase studies conducted with participation from our three Drug Development Units and clinics across our practice continue to reveal new discoveries in the use of targeted immunotherapies, radiopharmaceuticals, precision medicine and molecular-based treatments that effectively kill, block or inhibit the growth of cancer cells. The impact of our work is advancing the course of care for cancer patients on a global scale.
Disease Site Committee
Our Disease Site Committee is comprised of FCS medical oncologist and hematologist researchers who meticulously address the unique challenges and intricacies associated with site-specific types of cancer. By concentrating their expertise and resources, these teams are poised to drive groundbreaking advancements in the understanding, diagnosis, and treatment of cancer.
Barry Berman
Elizabeth Byron
Alpana Desai
Todd A. Gersten, MD
Shaachi Gupta
Eric Harris, DO
Bradley Monk, MD
Shachar Peles, MD
Marilyn M. Raymond, MD
Daniel L. Spitz, MD, FACP
Sumithra Vattigunta-Gopal, MD, FACP
Viralkumar Bhanderi, MD
Jeffrey A. Bubis, DO, FACOI, FACP
Paresh Patel, MD
Augusto E. Villegas, MD